Transfusion medicine
Medical specialty
Follow Transfusion medicine on Notably News to receive short updates to your email — rarely!
We include updates on Anemia, Blood type, Tranexamic acid, Rh blood group system, Platelet, Blood plasma, Gastrointestinal bleeding, Rh disease, Coombs test, Bleeding, ABO blood group system, Human leukocyte antigen, Kell antigen system, Hemolytic disease of the newborn, Hh blood group, Plasmapheresis ... and more.
| May 2025 |
Immunoglobulin therapy
Deqsiga was authorized for medical use in the European Union, offering a low IgA variant more suitable for patients with IgA deficiency.
|
| 2025 |
Anemia
Anemia is one of the six WHO global nutrition targets aimed at addressing global health challenges.
|
| February 2025 |
Immunoglobulin therapy
The Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending marketing authorization for Deqsiga, a new immunoglobulin therapy product by Takeda Manufacturing Austria AG.
|
| 2024 |
Autologous blood therapy
The Centers for Disease Control and Prevention (CDC) confirmed multiple HIV infections linked to vampire facial procedures performed in non-medical settings, raising serious safety concerns about the unregulated practice.
|
| 2023 |
Young blood transfusion
A study demonstrates that the rheumatoid arthritis drug anakinra can block IL-1B in elderly mice, effectively returning blood-producing stem cells in bone marrow to a more youthful state.
|
| 2023 |
Blood substitute
DARPA announced funding for twelve universities and labs to conduct synthetic blood research, with expected human trials anticipated between 2028-2030.
|
| 2022 |
Convalescent plasma
A resurgence in convalescent plasma usage began in the spring, particularly for treating immunocompromised patients when Omicron sublineages proved non-responsive to existing monoclonal antibody treatments.
|
| 2022 |
Er blood group system
Er was promoted from a blood group collection to a full blood group system, signifying its increased scientific importance and understanding.
|
| 2022 |
Autologous blood therapy
A scientific study on ME/CFS patients was conducted using oxygen-ozone autohemotherapy, involving 220 patients treated with at least two 30-minute sessions per week for multiple weeks. The study showed statistically significant improvements in fatigue symptoms, with 43.5% of patients experiencing symptom reduction from a score of 7 to 1. However, the study lacked a control group and did not establish the mechanism of action behind the improvements.
|
| April 27 2022 |
Convalescent plasma
An online petition was launched asking the World Health Organization to revise its guidelines on convalescent plasma usage, which were originally issued in December 2021.
|
| May 2021 |
Immunoglobulin therapy
Human normal immunoglobulin (Cutaquig) was approved for medical use in Australia, providing a new subcutaneous immunoglobulin treatment option.
|
| 2020 |
Convalescent plasma
The Mayo Clinic launched an Expanded Access Program for convalescent plasma in the United States, followed by an Emergency Use Authorization from the FDA.
|
| 2020 |
Young blood transfusion
A comprehensive review of plasma components that change with age identifies several candidate anti-aging and pro-aging factors, contributing to understanding of blood-based aging mechanisms.
|
| 2020 |
Convalescent plasma
Convalescent plasma therapy was first used in isolated cases and small series in China and Italy during the early stages of the COVID-19 pandemic.
|
| 2020 |
Anemia
Cochrane Anaesthesia Review Group conducted a review of erythropoietin (EPO) plus iron versus control treatment for preoperative anemic adults undergoing non-cardiac surgery, examining the effectiveness of erythropoiesis-stimulating agents in reducing red cell transfusions.
|
| May 2020 |
Immunoglobulin therapy
The United States approved a phase three clinical trial to investigate the efficacy and safety of high-concentration intravenous immune globulin therapy for treating severe COVID-19 patients.
|
| 2019 |
Young blood transfusion
The U.S. Food and Drug Administration (FDA) cautioned consumers against receiving young donor plasma infusions, declaring them an 'unproven treatment' and raising significant safety concerns about the practice.
|
| 2019 |
Convalescent plasma
A novel coronavirus (SARS-CoV-2) causing COVID-19 was first identified in Wuhan, China, marking the beginning of the global pandemic.
|
| 2019 |
Tranexamic acid
Canadian authorities recalled a Yunnan Baiyao toothpaste due to unauthorized presence of tranexamic acid.
|
| February 19 2019 |
Young blood transfusion
Ambrosia announces it has stopped testing the young blood transfusion treatment in response to FDA concerns.
|
| 2018 |
Stem cell fat grafting
National Statistical Office recorded 1,924 plastic surgeons in South Korea, with the Korean Plastic Surgery Association estimating non-specialists at approximately 10 times the number of specialists.
|
| 2017 |
Stem cell fat grafting
South Korean government invested highest proportion (13%) of bio sector funding into new drug development, allocating $112 million to stem cell research.
|
| 2017 |
Stem cell fat grafting
CartistemTM, Inc. Medipost successfully developed stem cell-based degenerative knee cartilage therapy and achieved over 10 billion in sales.
|
| 2016 |
Stem cell fat grafting
Korean stem cell markets formed a scale of $1.1 billion, with projections to grow 26.67% annually by 2025 to reach $9.5 billion.
|
| 2016 |
Young blood transfusion
Ambrosia startup begins selling 'young blood transfusions' for $8,000, framing the service as a clinical trial to investigate potential blood changes in recipients.
|
| 2013 |
Anemia
Anemia due to iron deficiency resulted in approximately 183,000 deaths globally, showing a reduction from 1990 levels.
|
| 2013 |
Autologous blood therapy
Kim Kardashian West publicly shared an Instagram post featuring her 'vampire facial' procedure, bringing widespread media attention to this controversial autologous blood therapy technique.
|
| 2012 |
Anemia
World Health Assembly endorsed global diet-related targets that included addressing anemia.
|
This contents of the box above is based on material from the Wikipedia articles Autologous blood therapy, Blood substitute, Immunoglobulin therapy, Complement component 4, Er blood group system, Convalescent plasma, Exchange transfusion, Stem cell fat grafting, Leukoreduction, Tranexamic acid, Anemia & Young blood transfusion, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.